Effectiveness of Innovative Educational Methods in Empowering Children With Sickle Cell Disease

NCT07802210 | Not Yet Recruiting

• 1 other identifier: UB.SCD.adolescent.pt
• Study Type: interventional
• Target: 120
• Locations: 1 country
• Sites: 1

Brief Summary

Sickle-cell disease (SCD) is a genetic disorder that affects hemoglobin, the molecule in red blood cells responsible for carrying oxygen. The disease causes red blood cells to become rigid and sickle-shaped, leading to blockages in blood flow and subsequent pain and organ damage (World Health Organization (WHO),2025). Patients with sickle cell disease suffer from various complications of the disease during their lifetime, including anemia, sickle cell crises, acute chest syndrome, stroke, renal failure, retinal detachment and priapism. However, unforeseen and chronic pain crisis are the most common symptoms reported by the patients which are considered as the most common causes of referral to the emergency department and hospital to receive medical care in sickle cell patients (Poku, Atkin,\& Kirk,.2023). Objective(s) of the study:

1. 1.To evaluate the effectiveness of Innovative Educational Methods on self-efficacy in children with sickle cell anemia.
2. 2.To evaluate the effectiveness of Innovative Educational Methods on self-care capacity in children with sickle cell anemia.
3. 3.To find out the relationship between the effectiveness of Innovative Educational Methods on self-efficacy, self-care capacity and demographic characteristics of children with sickle cell anemia.

Conditions

Sickle Cell Anemia in Children

Keywords

sickle cell disease; sickle cell anemia; innovative educational; self efficacy; self care agency

Outcome Measures

Primary Outcomes (2)

• self-care capacity level

  The Appraisal of Self-Care Agency Scale-Revised (ASA-R) According to Orem's self-care theory, Kearney and Fleischer originally developed this scale to assess the health-related self-care capacity level The scale consists of 15 items,

  pre and immediately post intervention and post 2 after 1 month

• self efficacy

  Sickle Cell Self-Efficacy Scale (SCSES): The Sickle Cell Self-Efficacy Scale, adapted from Edwards et al. (2001), was used to assess patients' abilities to manage their SCD and carry out daily activities effectively.

  pre and immediately post intervention and post 2 after 1 month

Study Arms (3)

video intervention arm

EXPERIMENTAL

participation in this arm will watch video

Other: video intervention

game intervention arm

EXPERIMENTAL

participation in this arm will play educational game

Other: game intervention

control arm

NO INTERVENTION

participation on this arm will not receive any video or game

Interventions

game intervention OTHER

Participants in this group will play an educational game . The game covers key information about anemia, including its definition, pathophysiology, symptoms, underlying causes, potential complications, and preventive pain crisis in simple way by use AI programs to generation it .

game intervention arm

video intervention OTHER

Participants in this group will watch an educational video lasting under 5 minutes. The video covers key information about anemia, including its definition, pathophysiology, symptoms, underlying causes, potential complications, and preventive pain crisis in simple way by use AI programs to generation it ."

video intervention arm

Eligibility Criteria

• Age: 11 Years - 18 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64)

You may qualify if:

• children with sickle cell anemia and visited Ibn Al-Baladi ,Al-Karamah center for hereditary blood diseases
• age 12-18 years
• being able to read and write
• agrees and willing to participate in the study

You may not qualify if:

• children who have a history of mental illness
• children with advanced complications of SCD, such as multi-system organ damage

Sponsors & Collaborators

• Aula Ibrahim abd alrazak: lead

Study Sites (1)

Pediatric Hematology Center - Ibn Al-Baladi Maternity & Children Hospital and Hereditary Blood Diseases Center, Al-Karamah Teaching Hospital, Baghdad government.

Baghdad, Baghdad Governorate, Iraq

Location

MeSH Terms

Conditions

Anemia, Sickle Cell

Condition Hierarchy (Ancestors)

Anemia, Hemolytic, Congenital; Anemia, Hemolytic; Anemia; Hematologic Diseases; Hemic and Lymphatic Diseases; Hemoglobinopathies; Genetic Diseases, Inborn; Congenital, Hereditary, and Neonatal Diseases and Abnormalities

Central Study Contacts

aula I Al Ali, Phd student

CONTACT

0096407733617988; ula.ibrahim1204a@conursing.uobaghdad.edu.iq

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: P.h.d student

Study Record Dates

• First Submitted: August 29, 2026
• First Posted: September 3, 2026
• Study Start: September 1, 2026
• Primary Completion (Estimated): December 1, 2026
• Study Completion (Estimated): December 1, 2026
• Last Updated: September 3, 2026

Record last verified: 2026-08

Data Sharing

• IPD Sharing: Will not share

Locations

IR (1)